Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Nephrology (Carlton) ; 25(11): 822-828, 2020 Nov.
Article in English | MEDLINE | ID: covidwho-913640


AIM: The COVID-19 pandemic poses unprecedented operational challenges to nephrology divisions in every country as they cope with COVID-19-related kidney disease in addition to regular patient care. Although general approaches have been proposed, there is a lack of practical guidance for nephrology division response in a hospital facing a surge of cases. Here, we describe the specific measures that our division has taken in the hope that our experience in Singapore may be helpful to others. METHODS: Descriptive narrative. RESULTS: A compilation of operational responses to the COVID-19 pandemic taken by a nephrology division at a Singapore university hospital. CONCLUSION: Nephrology operational readiness for COVID-19 requires a clinical mindset shift from usual standard of care to a crisis exigency model that targets best outcomes for available resources. Rapid multi-disciplinary efforts that evolve flexibly with the local dynamics of the outbreak are required.

Civil Defense , Coronavirus Infections , Critical Pathways/trends , Group Practice , Kidney Diseases , Pandemics , Pneumonia, Viral , Renal Insufficiency, Chronic , Betacoronavirus , COVID-19 , Civil Defense/standards , Civil Defense/statistics & numerical data , Coronavirus Infections/epidemiology , Coronavirus Infections/physiopathology , Coronavirus Infections/therapy , Group Practice/organization & administration , Group Practice/trends , Hospitals, University , Humans , Interdisciplinary Communication , Kidney Diseases/diagnosis , Kidney Diseases/epidemiology , Kidney Diseases/virology , Nephrology/trends , Organizational Innovation , Patient Care Management/methods , Patient Care Management/organization & administration , Pneumonia, Viral/epidemiology , Pneumonia, Viral/physiopathology , Pneumonia, Viral/therapy , Renal Insufficiency, Chronic/epidemiology , Renal Insufficiency, Chronic/therapy , SARS-CoV-2 , Singapore/epidemiology